“Militia Hill is an accomplished and highly respected team at the cutting edge of transforming promising immunotherapy, gene therapy and other innovations into companies that are positioned to thrive, grow and ultimately deliver relief to patients and cures for devastating diseases. It is an honor to be part of such urgent and worthwhile work,” McGinty said in a release announcing her position.
MHV is a firm that helps create and develop life sciences companies in the Philadelphia area. MHV is a woman-owned company.
With our focus on identifying transformative science from around the world into promising companies that tap into the vast wealth of talent that Greater Philadelphia offers, Katie McGinty will be a powerful asset for our vision,” Militia Hill Ventures Founding Managing Partner Dr. Joan Lau said in the announcement.
McGinty’s private sector resume includes serving at a Director with NRG Energy, a Senior Vice President and Managing Director with Weston Solutions, and an Operating Partner Element Partners.